Scarica l'app Stockscreener
86.17
2.05%
-1.80
Dopo l'orario di chiusura:
85.00
-1.17
-1.36%
Rhythm Pharmaceuticals Inc Azioni (RYTM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
18.54%
71.25
|
60.11 | 57.25 | 51.30 | 48.50 |
| Cost Of Revenue |
24.79%
8.931
|
7.157 | 4.802 | 5.499 | 5.543 |
Selling, General, and Administrative
|
6.07%
67.45
|
63.59 | - | - | - |
| Costs And Expenses |
6.52%
119.81
|
112.47 | 104.32 | 103.95 | 93.80 |
| Operating Income/Loss |
7.27%
-48.55
|
-52.36 | -47.06 | -52.65 | -45.30 |
| Nonoperating Income/Loss |
88.95%
-0.302
|
-2.733 | -0.473 | -0.14 | -0.999 |
| Income/Loss From Continuing Operations Before Tax |
11.33%
-48.85
|
-55.09 | -47.54 | -52.79 | -46.30 |
| Income Tax Expense/Benefit |
18.53%
0.444
|
0.545 | -0.031 | 0.111 | 0.337 |
|
Net Income/Loss
|
11.40%
-49.30
|
-55.64 | -47.51 | -52.90 | -46.63 |
| Basic Average Shares |
0.91%
68.59
|
67.97 | 0.6378 | 66.26 | 63.68 |
| Diluted Average Shares |
0.91%
68.59
|
67.97 | 0.6378 | 66.26 | 63.68 |
| Basic Earnings Per Share |
12.05%
-0.73
|
-0.83 | -0.73 | -0.82 | -0.75 |
| Diluted Earnings Per Share |
12.05%
-0.73
|
-0.83 | -0.73 | -0.82 | -0.75 |
0.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):